Where does Neutrace Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Neutrace Inc. ranks #16,232 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Neutrace Inc. hold?

Neutrace Inc. holds 18 US utility patents granted between 2023 and 2024, spanning 5 technology areas.

What is Neutrace Inc.'s Innovation Score?

Neutrace Inc. has an Innovation Score of 41.3 out of 100 (top 33% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Neutrace Inc. focus on?

Neutrace Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 7 patents, ranking #2,341 of 7,127 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Neutrace Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Neutrace Inc..

What does claim depth mean for Neutrace Inc.'s patents?

Neutrace Inc.'s patents average 5.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Neutrace Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Neutrace Inc.

USPTO PatentsView assignee record - 18 granted patents across 5 technology areas, recorded in grant years 2023–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neutrace ranks #16,232 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 5 technology areas.

#16,232
of 49,997 US assignees by volume: Top 33%
by Innovation Score (41.3/100): 5.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R16232 · US Corporation #16,232 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-SPARSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 18 grants
MID-PACK #16,232/49,997
PHOTO-FINISH Neatfreak Group
CPC-NARROW A61B · 5 areas
INNOV-PAR 41.3/100
CLAIMS-SPARSE 5.4 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2023–2024 · 2y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Neatfreak Group Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neutrace’s 41.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.2 pts (25%) Velocity 20.0 pts (48%) Breadth 7.9 pts (19%) Claim depth 3.3 pts (8%)

Qualcomm Incorporated · highest

85
Neutrace · this assignee

41
3D Lighting… · lowest

7

What this shows Neutrace's Innovation Score is 41.3/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Neutrace?

Each dot is one of Neutrace’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neutrace’s own 5.4 claims/patent is at or below the 9.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Neutrace vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neutrace's grants concentrate

Neutrace Inc. is a focused PatentsView assignee: 5 CPC subclasses with 38.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (16 grants) versus a trough of 2 in 2023. By volume, Neutrace sits between Neatfreak Group Inc. and Nira Dynamics AB.

Neutrace's three-year grant acceleration

Neutrace Inc. shows 18 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Neatfreak Group

18
NEC Network and S…

18
Neubrex

18
Neuronano AB

18
Ningbo Weie Techn…

18
Nippon Kodoshi

18
Nippon Valqua Ind…

18
Nira Dynamics AB

18
Neutrace ◀

18

What this shows Neutrace holds 18 patents at rank #16,219, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Neutrace

By rank, the assignees closest to #16,219 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Neutrace's primary technology class.

Neutrace's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 33% higher than 67% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Neutrace Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	2	11.1%
2024	16	88.9%

Which technologies does Neutrace Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 7

G06V - Image OR Video Recognition OR Understanding 2

G06T - Image Data Processing OR Generation, IN General 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Neutrace Inc.'s patent record in context - here's where to go next.

Neutrace Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 38.9% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #16,232 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Neutrace Inc. against Neatfreak Group Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.